Atterocor Receives $16,000,000 Series A Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fd160b91-91e2-44a8-87f5-89a9b0f3ebc7&Preview=1
Date 8/6/2012
Company Name Atterocor
Mailing Address 820 Heatherway Ann Arbor, MI 48104
Company Description Atterocor is an innovative company focused on the accelerated development of a treatment for adrenal cancer. Founded in 2012 and backed by top-tier life sciences investors, Atterocor is based in Ann Arbor, Michigan.
Proceeds Purposes Frazier Healthcare and 5AM Ventures led the round and proceeds from the financing will support Atterocor’s accelerated development of its lead program.